Assessment of the role of the Xpert Bladder Cancer detect assay in patients with asymptomatic hematuria

Assessment of the role of the Xpert Bladder Cancer detect assay in patients with asymptomatic hematuria - Role of Xpert Detect Bladder Cancer assay in hamaturia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027469

Enrollment

350

Registered

2022-01-21

Start date

2021-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R31 D41.4 C67

Interventions

Group 1: Voited urine from patient (4,5 ml) will be transferred to the transportation tube (provided by the company) and send to the house lab to perform an assay.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: hematuria

Exclusion criteria

Exclusion criteria: known bladder tumor

Design outcomes

Primary

Measure	Time frame
Exclusion / evidence of a bladder tumor	—

Secondary

Measure	Time frame
Predictive value of tumor markers	—

Countries

Germany

Contacts

Public ContactNatalya Benderska-Söder

Urologie24 gGmbH

n.benderska@urologie24.de+49-911-9608315

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026